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Abstract 
Background: Mass anti-malarial administration has been proposed as a key component of the malaria elimination 
strategy in South East Asia. The success of this approach depends on the local malaria epidemiology, nature of the 
anti-malarial regimen and population coverage. Community engagement is used to promote population coverage 
but little research has systematically analysed its impact. This systematic review examines population coverage and 
community engagement in programmes of mass anti-malarial drug administration.
Methods: This review builds on a previous review that identified 3049 articles describing mass anti-malarial adminis-
trations published between 1913 and 2011. Further search and application of a set of criteria conducted in the current 
review resulted in 51 articles that were retained for analysis. These 51 papers described the population coverage and/
or community engagement in mass anti-malarial administrations. Population coverage was quantitatively assessed 
and a thematic analysis was conducted on the community engagement activities.
Results: The studies were conducted in 26 countries: in diverse healthcare and social contexts where various anti-
malarial regimens under varied study designs were administered. Twenty-eight articles reported only population 
coverage; 12 described only community engagement activities; and 11 community engagement and population 
coverage. Average population coverage was 83% but methods of calculating coverage were frequently unclear or 
inconsistent. Community engagement activities included providing health education and incentives, using commu-
nity structures (e.g. existing hierarchies or health infrastructure), mobilizing human resources, and collaborating with 
government at some level (e.g. ministries of health). Community engagement was often a process involving various 
activities throughout the duration of the intervention.
Conclusion: The mean population coverage was over 80% but incomplete reporting of calculation methods limits 
conclusions and comparisons between studies. Various community engagement activities and approaches were 
described, but many articles contained limited or no details. Other factors relevant to population coverage, such as 
the social, cultural and study context were scarcely reported. Further research is needed to understand the factors 
that influence population coverage and adherence in mass anti-malarial administrations and the role community 
engagement activities and approaches play in satisfactory participation.
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Background
Malaria remains a leading global health concern and 
although, in South East Asia, malaria-related morbidity 
and mortality has seen recent declines, the spread of drug 
resistant Plasmodium falciparum parasites poses serious 
challenges to prevention and control efforts [1]. If left 
uncontained, the likely spread of artemisinin-resistant P. 
falciparum from Asia to Africa would have a catastrophic 
impact in the region where malaria-related mortality is 
highest [2].
This scenario has prompted urgent efforts to elimi-
nate falciparum malaria in South East Asia [3, 4]. One 
approach, targeted malaria elimination (TME), com-
bines conventional malaria prevention and control activi-
ties (reinforcing the network of village malaria workers 
(VMWs) to deliver appropriate case management and 
distribute long-lasting insecticide-treated bed nets 
(LLINs), with the mass administration of an artemisinin 
combination therapy. The mass drug administration 
(MDA) component of TME entails delivering a curative 
anti-malarial dose to all individuals within a community, 
irrespective of malaria infection status, to interrupt local 
transmission [5].
Over the past century, MDA has been used as a strat-
egy for malaria control with varying degree of success 
[6]. Past mass anti-malarial administrations, which 
often entailed sub-therapeutic doses, have been blamed 
for accelerating drug resistance [5, 7]. This is less likely 
within TME because therapeutic doses of combination 
anti-malarials are administered [5–8]. Interrupting local 
transmission through MDA is dependent on several fac-
tors, particularly the local malaria epidemiology, the 
characteristics of the anti-malarial regimen, and popu-
lation coverage and adherence (Fig.  1). In recent years, 
modelling studies have been helpful in determining the 
level of coverage required in specific epidemiological 
situations to interrupt transmission [9]. The level of cov-
erage required to ensure the effectiveness of the MDA 
and how to define coverage is debatable particularly with 
regard to specifying numerator and denominator. For 
instance, many MDA studies, exclude pregnant women 
and young children because of concerns of toxicity. It 
is clear that the local social context and the community 
engagement activities that accompany the MDA influ-
ence coverage and adherence [9–17].
Community engagement is variously defined in the 
global health literature [18]. Some scholars emphasize 
community engagement as promoting ethical conduct 
of research, whereas other definitions focus on ‘work-
ing collaboratively’ with communities ‘to address issues 
affecting the well-being of those people’ [18, 19]. With 
regard to programmes of MDA, community engagement 
entails a range of activities—for example, employing 
community members and providing health education—
that often focus on promoting population coverage and 
adherence [14, 19–22]. Although recognized as influenc-
ing coverage, community engagement is often scarcely 
reported and, to date, little effort have been made to ana-
lyse the impact of specific community engagement activi-
ties or approaches on MDA coverage.
With a view to designing community engagement activ-
ities for TME across the Greater Mekong sub-region, a 
systematic review of community engagement and popu-
lation coverage within mass anti-malarial administrations 
was conducted [6, 23]. This article examines: (1) popula-
tion coverage, (2) community engagement activities and 
(3) the relationship between (1) and (2) in previous mass 
anti-malarial administrations.
Methods
This review builds upon an earlier Cochrane review of 
mass anti-malarial administrations by Poirot et  al. [23]. 
For the Cochrane review, the following databases were 
searched: Cochrane infectious diseases, Group Special-
ized Register, Cochrane central register of controlled 
trials (CENTRAL), Cochrane Library, MEDLINE+  , 
EMBASE, CABS Abstracts and LILACS (Additional 
file 1). Search terms were: A. Anti-malarials: exp Antima-
larials or exp malaria/or antimalarial* or anti-malarial* 
or schizonticidal* or gametocidal* or hypnozoiticidal* or 
drug* or treatment* or malaria* and B. Mass Administra-
tion: mass or coordinate* or administ* or distribut* or 
applicat* or use or therap* or treatment*.
From these searches, 3049 articles were retrieved and 
reviewed (Fig.  2). Of these articles, 241 were selected 
based on the eligibility for MDA [23]. Further review by 
Newby et  al. [6] identified 16 sub-studies that resulted 
in a total of 257 full text articles. These 257 articles were 
subjected to the exclusion criteria (Table 1). This resulted 
in 201 articles published between November 30, 1931 
and August 24, 2011 that were assessed for inclusion 
Probability of 
complete interruption 
of local malaria 
transmission










Fig. 1 Factors affecting the probability of completely interrupting 
local malaria transmission through mass antimalarial administration. 
Highlighted in grey are areas of concern for this review
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in the current review. To examine the maximum num-
ber of studies that might have documented commu-
nity engagement activities and population coverage, 
articles excluded from previous reviews were included: 
articles that reported MDA for sub-groups rather than 
entire populations, described the delivery of inadequate 
treatment doses, documented the mass screen and treat 
approach and those that were not unique MDA studies 
(e.g. multiple publications documenting different compo-
nents of the same study).
Two authors (BA and NJ) independently retrieved and 
reviewed the articles. Firstly, all the literature pertaining 
Fig. 2 Assembly of the reviewed literature
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to malaria-related MDAs was reviewed to extract popu-
lation coverage data. In this review, population cov-
erage has been defined as the total proportion of the 
target population who took anti-malarials with or with-
out directly observed treatment (DOT) during the entire 
course of the MDA. Secondly, the articles were sorted 
according to the reports of community engagement 
activities. Thirdly, a thematic analysis of the literature 
that addressed the population coverage and/or commu-
nity engagement was conducted.
Of the 201 articles, 181 reported primary studies and 
20 reported secondary studies, which gave additional 
details on the primary studies. Seventy-eight of the 181 
primary studies were excluded. These were 68 non Eng-
lish articles, eight that reported intermittent preven-
tive treatment (IPT) and two of which the full text were 
not available resulting in 103 studies. Among these 20 
secondary studies, nine were excluded: two were in lan-
guages other than English, one was an unpublished work-
ing document and six described studies indirectly related 
to MDA (such as knowledge, attitude and practice stud-
ies, and longitudinal studies), resulting in eleven second-
ary studies. Of these 11 studies, two were included in the 
previous review of community participation by Atkinson 
et al. [20]. These 11 articles were reviewed for their addi-
tional details on community engagement and coverage 
and were used to supplement the information detailed in 
Tables 2, 3 and 4.
Community engagement data extraction and analysis
Of the 103 primary articles, 47 were excluded after a 
preliminary review because they did not describe popu-
lation coverage or community engagement activities 
(Additional file 2). Among the remaining 56 articles, six 
described community engagement only very briefly and 
were excluded [24]. One additional article was added 
during the update of the review [25] resulting in 51 
articles retained for analysis. A thematic analysis was 
conducted on a total of 23 articles, which described com-
munity engagement activities. These included 12 articles 
that described community engagement activities only 
and 11 articles that described population coverage and 
community engagement activities.
Results
The nature of the reviewed articles
Fifty-one articles reporting the results of studies con-
ducted in 26 countries were retained in the analysis. 
Population coverage without community engagement 
was documented in 28/51 (55%) papers (Table 2). Twelve 
of 51 (24%) articles described community engagement 
activities in detail but not population coverage (Tables 3, 
5), whereas 11/51 (22%) articles described community 
engagement activities in detail and population cover-
age (Tables  4, 6). Among all articles reviewed (n =  51), 
median quartile of the studies were conducted before 
1965 (Q1 = 1956, Q2 = 1965 and Q3 = 1984).
The studies were conducted in contexts with diverse 
healthcare infrastructure, health needs, population 
mobility and population size. For instance, the study in 
Lebanon involved study villages, which were deprived 
of healthcare centres (physicians or pharmacies were 
unavailable within 18 km of the village). In addition, the 
study population was mobile as they often leave the vil-
lage in search of job and to escape the winter [26]. This 
had implications in terms of villagers’ willingness to fol-
low study instructions, such as not to take other anti-
malarials apart from the study drug, chloroquine.
In some cases, mass anti-malarial administration 
was conducted as part of research in selected villages, 
whereas, in others, MDA was part of a national health 
campaign. An example of the latter is Nicaragua where 
Table 1 Inclusion and exclusion criteria for review
Inclusion criteria to assess eligibility for review:
 1. All randomized and non-randomized studies of mass administration of anti-malarials, including cluster-randomized trials, non-randomized controlled studies and 
uncontrolled before-and-after studies that measured at least one outcome of interest in the target population
 2. Additional: inclusion of secondary papers related to MDA
Exclusion criteria to assess eligibility for review:
 1. Individually randomized studies
 2. Studies in which the primary focus was not MDA (e.g. historical program reviews that merely made mention of MDA activities, community surveys done in conjunction 
with MDA)
 3. Studies using an indirect approach to MDA, where anti-malarials are added to essential foodstuffs, usually dietary salt
 4. Historical accounts of mass quinine distribution in the early 20th century
 5. Studies targeting short-term residents of malaria endemic areas (e.g. military, laborers)
 6. Studies written in languages other than English
 7. All intermittent preventive treatment (IPT) studies (e.g. delivering treatment to infants and young children, treating malaria-related febrile illness, home based treat-
ments and comparison of delivery methods; factors that would greatly bias the choice of participation)
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the entire population was treated. High level of commu-
nity participation in a literacy campaign in previous year 
was a stimulus for the nationwide MDA. Prior to mass 
anti-malarial administration, health campaigns had been 
conducted for polio vaccination, sanitation and environ-
mental hygiene, rabies control in domestic pets and vac-
cination against diphtheria, pertussis and tetanus [27].
Population coverage
The 28 studies that documented only population cover-
age were published from 1931 to 1996 (Table  2). The 
mean reported population coverage in these 28 stud-
ies was 82% (range 40–100%), with seven (25%) studies 
reporting a population coverage below 79% (Table 2). The 
11 articles reporting both population coverage and com-
munity engagement activities were published from 1960 
to 2015 and described, on average, 84% coverage (range 
40–100%). Three of the 11 (27.3%) studies reported a 
population coverage below 79% (Table  4). It was often 
unclear or not specified how the coverage was estimated. 
For example, in Trinidad and Tobago, 2142 people were 
given plasmoquine and quinine, but only 1289 people 
completed the full course. In this study, the coverage was 
not reported and the selection of the target population 
was not mentioned [28]. Similarly, in Sudan, the anti-
malarials were reportedly taken by all members of the 
targeted population but no details of coverage, popula-
tion size or the selection procedure were provided [29].
Community engagement activities
This section describes the type and process of commu-
nity engagement activities: health education, provision of 
incentives, utilization of existing community structures, 
human resource mobilization and steps in community 
engagement.
Health education
Of the 23 articles (Tables 5, 6) with detailed descriptions 
of community engagement, 12 focused on health edu-
cation employing the following media and methods: (1) 
newspapers, written leaflets and posters, (2) audio-visual 
materials, such as news-bulletins, movies and videos, and 
(3) meetings with key community persons, announce-
ments in health facilities in conjunction with community 
members and involvement of local health workers, gov-
ernment health officials and village volunteers.
Two articles, reporting on studies in Nicaragua [30] and 
Indonesia [31] incorporated large-scale health education 
on malaria and MDA. Health education was conducted 
in various different contexts and various methods were 
applied. For instance, in Tanzania, articles for the gen-
eral public were written in two local newspapers [32]. In 
Ghana, weekly health education classes were conducted 
among the residents and they were asked to spread the 
message to other villagers [33]. In India, health education 
sessions were conducted in different levels where com-
munity health volunteers played a major role in increas-
ing the awareness in the community [34]. In Vanuatu, 
intensive health education classes were conducted after 
coverage dropped and in subsequent round coverage 
improved [14, 35]. Information dissemination was con-
ducted through newspapers [32], pamphlets and news 
bulletins [36]. In two studies [37, 38] audio-visual mate-
rials were employed to explain the planned interven-
tion [37]. In China, the health education was delivered 
through the primary health care system by the means of 
meetings, films, posters and videos [38].
Incentives
Two articles documented the use of incentives in MDA 
but they did not report the corresponding popula-
tion coverage [37, 39]. In Venezuela, MDA participants 
received incentives ranging from a lottery ticket to sugar 
candy on completion of the entire anti-malarial course. 
In addition, financial incentives were provided to MDA 
staff for each malaria positive slide [39]. In India, finan-
cial incentives—an advance for housing construction—
were given to reluctant tribal populations [37].
Community structures
Community structures consisted of existing organiza-
tions, physical infra-structure, health care providers and 
health service centres. The involvement of community 
structures was often a core component of introducing 
the MDA to the target communities. In India, personnel 
from the local health centre and additional staff from the 
district assisted in conducting the MDA [34]. In Kenya, 
the MDA was implemented in the community through 
the local district health office [40]. Apart from conduct-
ing community meetings and utilizing community struc-
tures, a study [25] in Thai–Myanmar border areas utilized 
an existing community ethics advisory board (Tak Prov-
ince Community Ethics Advisory Board [T-CAB]) [41].
Human resource mobilization
Human resource mobilization varied from the simple 
involvement of community members or health staff to 
assist with the study to complete hand over of the MDA 
operations to government staff. For instance, in the 
Gambia, a translator and a fieldworker were appointed 
for consent process with participants whereas the staff 
at health centre recorded the visits of villagers at health 
centre [42]. In Cambodia, village malaria workers were 
recruited to distribute the drugs and monitor drug 
administration [43]. By contrast, in Nicaragua, a nation-
wide malaria control program recruited 70,000 people as 
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anti-malaria volunteers who were trained to conduct the 
census, provide door to door education, promote com-
munity participation, distribute drugs and keep records 
[27]. On Aneityum Island, Vanuatu, village volunteers 
were selected and trained as MDA staff and were respon-
sible for drug distribution [35].
Steps in community engagement
Community engagement was often a process and the 
MDAs involved participants in various ways through-
out the duration of the intervention. For instance, in 
The Gambia, researchers first discussed the project with 
and sought cooperation from national and district-level 
members of governmental and health structures. Subse-
quently, meetings were conducted in the target commu-
nities with village elders and other prominent residents 
in the presence of the government officials [42]. With the 
consent of village leaders, meetings were held with com-
munity members to introduce the purpose and details 
of the study, which was then followed by the individual 
consent process. On Aneityum Island, the MDA plan was 
first formulated by the malaria control programme at the 
Department of Health. Operationally, MDA was led by 
the district malaria supervisor and several meetings were 
held with the communities to explain the MDA’s pur-
pose and procedures, and to elicit the community’s full 
commitment to eliminate malaria from the island. Sub-
sequently, 12 village volunteers were selected and trained 
as MDA staff and anti-malarial administration was car-
ried out with the supervision of a registered nurse who 
was responsible for healthcare on the island, the district 
malaria supervisor and central malaria section staff [14, 
35].
The relationship between community engagement 
and population coverage
Among the 11 studies (Tables 4, 6) that documented both 
community engagement activities and coverage, coverage 
ranged from 40 to 100% [25, 27, 34, 35, 40, 42, 44, 45]. 
The MDA with the highest reported population coverage 
(100%) was part of the North Sumatra Health Promotion 
Project, Indonesia and was on-going for 10 years. In this 
national initiative, existing village health centres and staff 
were responsible for the activities, such as collecting fin-
gertip blood samples and examining spleen size. Two vil-
lage volunteers also worked as recorders and guides and 
the primary school teacher assisted in identifying and 
examining pupils [44].
Another successful MDA that reached 95% of the 
target population was conducted in Kenya, as part of 
chemotherapeutic campaigns in 1953–1954 and as a 
joint collaboration between WHO, UNICEF and Minis-
try of Health. In this case, the district health offices were 
responsible for overall organization and supervision of 
the MDA and the district health inspector was charged 
with the daily running of the operation. Most community 
leaders, such as administrative chiefs, headmen, school 
teachers and clerks were involved [40].
On Aneityum Island, mass anti-malarial administration 
contributed to the elimination of malaria from the island. 
Here, the department of health was closely involved: the 
district malaria supervisor took charge of the programme 
and delegated responsibilities to local staff from govern-
ment health facilities. Twelve community members were 
recruited and trained as MDA staff who carried out day-
to-day activities, such as drug distribution, recording and 
supervision. The MDA compliance rate decreased from 
90 to 79% in the 2nd and 3rd rounds; this resulted from 
the adverse events related to chloroquine and the num-
ber of tablets participants had to take and, in response, 
community meetings were held. Additional informa-
tion was provided and chloroquine was removed from 
the scheduled anti-malarial regimen in the 5th and 9th 
rounds after discussion with the community [14, 35].
Amongst the articles that reported coverage and com-
munity engagement activities, the lowest coverage −40%-
was recorded on the Thai–Myanmar border [25]. Initially, 
the mean coverage in three villages for the malaria para-
site survey was 77%. After discussing the results with 
community leaders and the T-CAB, MDA was agreed 
as an intervention. Two of the three villages were inac-
cessible during the rainy season and so anti-malarials 
could not be administered there. The low coverage was 
explained in terms of political fragmentation, inaccessi-
bility and high mobility [25].
Discussion
This review has identified and examined reports of mass 
anti-malarial administrations that described commu-
nity engagement activities and/or population coverage. 
Conducted between December 30, 1931 and August 16, 
2015, MDAs varied widely by anti-malarial regimen, 
study type, context, community engagement activities, 
and population coverage. In the following sections, the 
research questions are discussed with particular regard 
to the limitations of the reviewed articles.
Population coverage
Amongst the reviewed articles, the mean population 
coverage for the mass anti-malarial administrations 
was above 80%, the suggested minimum to interrupt 
malaria transmission [6]. Amongst the articles that 
described population coverage and community engage-
ment activities, the mean was even higher. Furthermore, 
when community engagement involved government 
and local community structures, coverage was above 
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85% (range =  70–100%) [27, 34, 35, 40, 42, 44, 45] and 
when community engagement activities depended on 
the community alone, mean coverage was over 80% 
(range = 40–95%) [12, 25, 31, 46]. These figures suggest 
cause for optimism with regard to reaching the levels of 
coverage required to eliminate falciparum malaria from 
the Greater Mekong sub-region.
The reporting of how population coverage was calcu-
lated was, often absent or inadequate; little detail was 
offered on the denominator or numerator populations, 
who was excluded, for example, from anti-malarial 
administration, or how the total target population was 
calculated, with regard to including or excluding mobile 
groups. The absence of such detail limits direct compari-
sons across the studies. Ideally, future research on mass 
anti-malarial administration should report its fullness, 
the methods used to calculate population coverage.
The reviewed articles also provide few references to 
participants’ adherence to the anti-malarial regimen 
[31, 35, 36, 45, 47]. Adherence is likely to be a particu-
lar challenge when administering a multi-dose multi-
day anti-malarial regimens. Although adherence can be 
ensured by delivering anti-malarials as DOT, this is likely 
to present challenges when part of large scale MDA pro-
gramme.  Low-prevalence settings, such as those in the 
Greater Mekong sub-Region, are also likely to present 
potential challenges for adherence if DOT is not possi-
ble. Future research should address the question of MDA 
adherence in areas of low clinical malaria prevalence.
Community engagement activities
The reviewed articles described community engagement 
activities that included the simple provision of informa-
tion about the MDA to the community, the utilization of 
existing community structures for MDA implementation, 
delivery of health education, and building local human 
resource capacity through training. Some articles pro-
vided detailed accounts of the community engagement 
[14, 30], overall, there was a general lack of detail regard-
ing the approach to community engagement and the 
activities conducted.
Community engagement approaches have been catego-
rized as top-down (vertical) and bottom-up (horizontal) 
[20]. Many of the reviewed articles reported a combina-
tion of these approaches [27, 34, 35, 40, 42, 44, 45] and 
community engagement was often a process, involving 
multiple steps. First, the top-down approach was used to 
garner support of officials and gain access to the research 
site [48, 49]. In light of the criticisms of such an approach 
and the need to gain the consensus of the community, 
more bottom-up activities were subsequently utilized 
[50–52]. This is particularly the case in more recent 
MDAs [48, 53–55]. In many of the reviewed articles, [12, 
27, 31, 34, 35, 40, 42, 44–46], the use of existing commu-
nity structures, the local health system and involvement 
of the community in meetings, health education and 
training of the local staff were essential features.
Bottom-up approaches to community engagement 
include community-directed interventions (CDI), which 
entails community members taking an active role in the 
planning and execution of an intervention. For MDAs, 
such activities include carrying out the target population 
census, distributing drugs, mobilizing other community 
members and recording treatments provided [14, 27, 43]. 
In the reviewed Vanuatu study, 12 village volunteers were 
selected and trained as MDA staff who delivered each 
MDA dose under supervision. A multi-country review 
of CDIs to control and manage tropical diseases, includ-
ing malaria, identified this approach as more effective at 
increasing coverage and achieving the targeted outcome 
compared to conventional vertical approaches [21, 22]. 
This approach was also more cost effective and opera-
tionally efficient with community members’ enthusiasm 
described as pivotal in increasing feasibility and sustain-
ability [22].
Analysing and comparing the community engagement 
activities is complicated by the diverse study conditions 
under which the MDAs were undertaken. These included 
controlled trials, which entailed close monitoring of par-
ticipants, whereas others were less intensive implemen-
tation studies. Aspects of these controlled clinical trials, 
such as the provision of incentives (and/or healthcare), 
would not be feasible as part of a larger implementation 
and only qualified lessons can be drawn from such stud-
ies. With regard to incentives, during a multi-country 
study in Africa, the effects of different incentives types 
were compared: material incentives, such as gift items, 
money or T-shirts were less effective than “intrinsic” 
incentives, such as sense of recognition, the feeling of 
making a worthwhile contribution and knowledge gained 
[21, 22].
In most of the reviewed MDAs, community engage-
ment activities focused on promoting the population 
coverage and facilitating study operations. However, for 
many researchers, community engagement now encom-
passes the broader aim of promoting ethical global health 
research through, for example, socially responsible 
knowledge production, capacity development and health 
promotion, such as through changes in health behaviour 
[19, 56, 57]. From this perspective, community engage-
ment cannot be simply evaluated in terms of its contribu-
tion to the study aims, in the case of mass anti-malarial 
administration, mainly population coverage.
The local social and cultural context also influences 
MDA coverage and adherence in various ways: for exam-
ple, community members’ familiarity with anti-malarials, 
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perceptions about the seriousness of malaria and its 
local prevalence can influences people’s readiness to 
take medicines when apparently healthy. The nature of 
the anti-malarial, particularly any adverse events that 
are associated with it and how they are interpreted with 
regard to local understandings of illness, is also likely to 
influence community responses to the intervention. Sim-
ilarly, the local availability of healthcare prior to the study 
could influence participation. Political divisions within 
the target community, perceived or enacted nepotism 
can foster resentment and objections towards MDA.
Strengths and limitations
This review is the first comprehensive analysis of the 
published literature on community engagement and pop-
ulation coverage in mass anti-malarial administrations. 
The findings are limited by the relatively low proportion 
of articles that documented community engagement 
activities (45%; 23/51). The findings are also limited by 
the heterogeneity of study methods, population and 
study sites. This is particularly relevant in terms of the 
methods used to calculate population coverage, which 
was often reported with insufficient detail to ensure fair 
comparisons.
Conclusion
The reviewed MDAs varied widely by anti-malarial regi-
men, study design, context, era, community engagement 
activities, and population coverage. The mean popula-
tion coverage for the reviewed mass anti-malarial admin-
istrations was above 80%, but inadequate reporting of 
coverage calculation methods complicates comparisons 
between studies. Various community engagement activi-
ties and approaches were described, many of which con-
tained limited or no details. Community engagement 
plays a major role in achieving high population cover-
age in mass anti-malarial administrations. Amongst the 
reviewed articles, coverage was highest when commu-
nity engagement involved government and community 
structures, such as in Nicaragua and on Aneityum island. 
Other factors, such as the social, cultural and study con-
text, may also play an important role but were not inves-
tigated by these articles. More research is needed to 
disentangle the factors influencing population coverage, 
adherence, “success” in mass anti-malarial administra-
tions and the role of community engagement activities 
and approaches. Future research must also (1) report in 
full the methods used to calculate population coverage; 
(2) provide details of community engagement activities; 
and (3) evaluate the impact of the local social context as 
well as the particular community engagement activities 
and strategies.
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